Suivre
Joseph Fadare
Joseph Fadare
Professor of Clinical Pharmacology and Therapeutics, College of Medicine, Ekiti State University
Adresse e-mail validée de eksu.edu.ng
Titre
Citée par
Citée par
Année
Response to the novel corona virus (COVID-19) pandemic across Africa: successes, challenges, and implications for the future
OO Ogunleye, D Basu, D Mueller, J Sneddon, RA Seaton, ...
Frontiers in pharmacology 11, 1205, 2020
2322020
Barriers for access to new medicines: searching for the balance between rising costs and limited budgets
B Godman, A Bucsics, P Vella Bonanno, W Oortwijn, CC Rothe, A Ferrario, ...
Frontiers in Public Health 6, 328, 2018
1852018
Drug prescription pattern in a Nigerian tertiary hospital
I Tamuno, JO Fadare
Tropical Journal of Pharmaceutical Research 11 (1), 146-152, 2012
1782012
Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries …
B Godman, M Haque, J McKimm, M Abu Bakar, J Sneddon, J Wale, ...
Current medical research and opinion 36 (2), 301-327, 2020
1722020
Antibiotic self-medication among university medical undergraduates in Northern Nigeria
JO Fadare, I Tamuno
J Public Health Epidemiol 3 (5), 217-220, 2011
1592011
Knowledge, attitude and practice of adverse drug reaction reporting among healthcare workers in a tertiary centre in Northern Nigeria
JO Fadare, OO Enwere, AO Afolabi, BAZ Chedi, A Musa
Tropical Journal of Pharmaceutical Research 10 (3), 2011
1582011
Review of ongoing activities and challenges to improve the care of patients with type 2 diabetes across Africa and the implications for the future
B Godman, D Basu, Y Pillay, JC Mwita, GM Rwegerera, ...
Frontiers in pharmacology 11, 108, 2020
1382020
Prescription pattern and prevalence of potentially inappropriate medications among elderly patients in a Nigerian rural tertiary hospital
JO Fadare, SM Agboola, OA Opeke, RA Alabi
Therapeutics and clinical risk management, 115-120, 2013
1192013
Status of antimicrobial stewardship programmes in Nigerian tertiary healthcare facilities: findings and implications
JO Fadare, O Ogunleye, G Iliyasu, A Adeoti, N Schellack, D Engler, ...
Journal of global antimicrobial resistance 17, 132-136, 2019
1132019
Triglyceride-glucose index and related parameters predicted metabolic syndrome in Nigerians
TH Raimi, BF Dele-Ojo, SA Dada, JO Fadare, DD Ajayi, EA Ajayi, ...
Metabolic syndrome and related disorders 19 (2), 76-82, 2021
1112021
Medication adherence and direct treatment cost among diabetes patients attending a tertiary healthcare facility in Ogbomosho, Nigeria
J Fadare, M Olamoyegun, BA Gbadegesin
Malawi medical journal 27 (2), 65-70, 2015
1092015
Fixed dose drug combinations–are they pharmacoeconomically sound? Findings and implications especially for lower-and middle-income countries
B Godman, H McCabe, T D Leong, D Mueller, AP Martin, I Hoxha, ...
Expert review of pharmacoeconomics & outcomes research 20 (1), 1-26, 2020
1042020
Self-medication among health workers in a tertiary institution in South-West Nigeria
OA Babatunde, JO Fadare, OJ Ojo, KA Durowade, OA Atoyebi, PO Ajayi, ...
The Pan African medical journal 24, 2016
982016
The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians
JO Fadare, AO Adeoti, OO Desalu, OO Enwere, AM Makusidi, O Ogunleye, ...
Expert review of pharmacoeconomics & outcomes research 16 (5), 639-650, 2016
962016
Use of herbal medicine among pregnant women attending a tertiary hospital in Northern Nigeria
I Tamuno, A Omole-Ohonsi, J Fadare
The Internet Journal of Gynecology and Obstetrics 15 (2), 53-56, 2011
922011
Drug prescribing pattern for under-fives in a paediatric clinic in South-Western Nigeria
F Joseph, O Oladele, O Oludare, O Olatunde
Ethiopian journal of health sciences 25 (1), 73-78, 2015
892015
The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective
S Ansari, JP Hays, A Kemp, R Okechukwu, J Murugaiyan, MD Ekwanzala, ...
JAC-antimicrobial resistance 3 (2), dlab038, 2021
842021
Tackling antimicrobial resistance across sub-Saharan Africa: Current challenges and implications for the future
B Godman, A Egwuenu, E Wesangula, N Schellack, AC Kalungia, ...
Expert Opinion on Drug Safety 21 (8), 1089-1111, 2022
832022
The financial burden of sickle cell disease on households in Ekiti, Southwest Nigeria
OS Olatunya, EO Ogundare, JO Fadare, IO Oluwayemi, OT Agaja, ...
ClinicoEconomics and outcomes Research, 545-553, 2015
812015
Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): A narrative review and the implications
Z Saleem, B Godman, F Azhar, AC Kalungia, J Fadare, S Opanga, ...
Expert review of anti-infective therapy 20 (1), 71-93, 2022
742022
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20